Crocetin Enhances Temozolomide Efficacy in Glioblastoma Therapy Through Multiple Pathway Suppression

被引:0
|
作者
Tsai, Wei-En [1 ]
Liu, Yen-Tsen [1 ]
Kuo, Fu-Hsuan [2 ]
Cheng, Wen-Yu [3 ,4 ,5 ,6 ]
Shen, Chiung-Chyi [3 ,4 ,7 ]
Chiao, Ming-Tsang [3 ]
Huang, Yu-Fen [3 ]
Liang, Yea-Jiuen [3 ]
Yang, Yi-Chin [3 ]
Hsieh, Wan-Yu [3 ]
Chen, Jun-Peng [8 ]
Liu, Szu-Yuan [9 ,10 ]
Chiu, Cheng-Di [11 ,12 ]
机构
[1] Taichung Municipal Taichung First Sr High Sch, Taichung, Taiwan
[2] Taichung Vet Hosp, Ctr Geriatr & Gerontol, Taichung 40705, Taiwan
[3] Taichung Vet Gen Hosp, Neurol Inst, Dept Minimally Invas Skull Base Neurosurg, Taichung, Taiwan
[4] Hung Kuang Univ, Dept Phys Therapy, Taichung, Taiwan
[5] Natl Chung Hsing Univ, Inst Biomed Sci, Taichung, Taiwan
[6] Natl Chung Hsing Univ, Coll Med, Dept Postbaccalaureate Med, Taichung, Taiwan
[7] Cent Taiwan Univ Sci & Technol, Basic Med Educ, Taichung, Taiwan
[8] Taichung Vet Gen Hosp, Biostat Task Force, Taichung, Taiwan
[9] Taichung Vet Gen Hosp, Neurol Inst, Dept Neurosurg, Oncol Neurosurg Div, Taichung, Taiwan
[10] Natl Chung Hsing Univ, Grad Inst Life Sci, Coll Life Sci, Dept Life Sci, Taichung, Taiwan
[11] China Med Univ Hosp, Spine Ctr, Taichung, Taiwan
[12] China Med Univ Hosp, Dept Neurosurg, Taichung, Taiwan
关键词
Crocetin; glioblastoma; temozolomide; AKT signaling; cell migration; ACTIVATED PROTEIN-KINASES; MOBILITY GROUP BOX-1; CROCUS-SATIVUS; CELL-MIGRATION; CANCER-CELLS; ENDOTHELIAL-CELLS; GLIOMA CANCER; APOPTOSIS; GROWTH; METASTASIS;
D O I
10.2174/0115672026332275240731054001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Glioblastoma multiforme (GBM) is an aggressive type of braintumor that is difficult to remove surgically. Research suggests that substances from saffron, namely crocetin and crocin, could be effective natural treatments, showing abilities to kill cancer cells. Methods Our study focused on evaluating the effects of crocetin on glioma using the U87 cell line. We specifically investigated how crocetin affects the survival, growth, and spread of glioma cells, exploring its impact at concentrations ranging from 75-150 mu M. The study also included experiments combining crocetin with the chemotherapy drug Temozolomide (TMZ) to assess potential synergistic effects. Results Crocetin significantly reduced the viability, proliferation, and migration of glioma cells. It achieved these effects by decreasing the levels of Matrix Metallopeptidase 9 (MMP-9) and Ras homolog family member A (RhoA), proteins that are critical for cancer progression. Additionally, crocetin inhibited the formation of cellular structures necessary for tumor growth. It blocked multiple points of the Ak Strain Transforming (AKT) signaling pathway, which is vital for cancer cell survival. This treatment led to increased cell death and disrupted the cell cycle in the glioma cells. When used in combination with TMZ, crocetin not only enhanced the reduction of cancer cell growth but also promoted cell death and reduced cell replication. This combination therapy further decreased levels of high mobility group box 1 (HMGB1) and Receptor for Advanced Glycation End-products (RAGE), proteins linked to inflammation and tumor progression. It selectively inhibited certain pathways involved in the cellular stress response without affecting others. Conclusion Our results underscore the potential of crocetin as a treatment for glioma. It targets various mechanisms involved in tumor growth and spread, offering multiple avenues for therapy. Further studies are essential to fully understand and utilize crocetin's benefits in treating glioma.
引用
收藏
页码:320 / 336
页数:17
相关论文
共 50 条
  • [21] VITAMIN D3 ENHANCES TEMOZOLOMIDE EFFICACY IN GLIOBLASTOMA CELLS WHILE PROTECTING NORMAL ASTROCYTES: INVESTIGATING THE EFFECTS OF ADJUNCTIVE THERAPY
    Morelli, M.
    Di Lorenzo, F.
    Nannipieri, F.
    Trasciatti, S.
    Di Stefano, A.
    Lessi, F.
    Mazzanti, C.
    NEURO-ONCOLOGY, 2024, 26
  • [22] A Boronated Derivative of Temozolomide Showing Enhanced Efficacy in Boron Neutron Capture Therapy of Glioblastoma
    Xiang, Jing
    Ma, Lin
    Gu, Zheng
    Jin, Hongjun
    Zhai, Hongbin
    Tong, Jianfei
    Liang, Tianjiao
    Li, Juan
    Ren, Qiushi
    Liu, Qi
    CELLS, 2022, 11 (07)
  • [23] Encapsulation of Temozolomide in a Calixarene Nanocapsule Improves Its Stability and Enhances Its Therapeutic Efficacy against Glioblastoma
    Renziehausen, Alexander
    Tsiailanis, Antonis D.
    Perryman, Richard
    Stylos, Evgenios K.
    Chatzigiannis, Christos
    O'Neill, Kevin
    Crook, Timothy
    Tzakos, Andreas G.
    Syed, Nelofer
    MOLECULAR CANCER THERAPEUTICS, 2019, 18 (09) : 1497 - 1505
  • [24] Safety and efficacy of the addition of bevacizumab to temozolomide and radiation therapy followed by bevacizumab, temozolomide, and irinotecan for newly diagnosed glioblastoma multiforme
    Vredenburgh, James J.
    Desjardins, Annick
    Peters, Katherine B.
    Reardon, David A.
    Herndon, James Emmett
    Coan, April D.
    Kirkpatrick, John
    Bailey, Leighann
    Threatt, Stevie
    Sampson, John Howard
    Friedman, Allan H.
    Friedman, Henry S.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [25] Silence of bFGF enhances chemosensitivity of glioma cells to temozolomide through the MAPK signal pathway
    Wang, Qiong
    Du, Jixiang
    Xu, Bin
    Xu, Lixia
    Wang, Xiuyu
    Liu, Jun
    Wang, Jinhuan
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2016, 48 (06) : 501 - 508
  • [26] Talazoparib enhances low-dose temozolomide efficacy in flank glioblastoma models, but intracranial efficacy is constrained by limited brain distribution
    Kizilbash, Sani H.
    Chang, Kenneth
    Gupta, Shiv K.
    Kawashima, Ryo
    Parrish, Karen
    Mladek, Ann C.
    Carlson, Brett L.
    Bakken, Katrina K.
    Schroeder, Mark A.
    Kitange, Gaspar J.
    Decker, Paul A.
    Shen, Yucliao
    Elmquist, William F.
    Sarkaria, Jann N.
    CANCER RESEARCH, 2016, 76
  • [27] Efficacy of systemic temozolomide-activated phage-targeted gene therapy in human glioblastoma
    Przystal, Justyna Magdalena
    Waramit, Sajee
    Pranjol, Md Zahidul Islam
    Yan, Wenqing
    Chu, Grace
    Chongchai, Aitthiphon
    Samarth, Gargi
    Gene Olaciregui, Nagore
    Tabatabai, Ghazaleh
    Montero Carcaboso, Angel
    Aboagye, Eric Ofori
    Suwan, Keittisak
    Hajitou, Amin
    EMBO MOLECULAR MEDICINE, 2019, 11 (04)
  • [28] Bazedoxifene enhances paclitaxel efficacy to suppress glioblastoma via altering Hippo/YAP pathway
    Fu, Weiwei
    Zhao, Peng
    Li, Hong
    Fu, Haiyang
    Liu, Xuejun
    Liu, Yingchao
    Wu, Jie
    JOURNAL OF CANCER, 2020, 11 (03): : 657 - 667
  • [29] INDUCTION OF THE ASTROCYTIC LINEAGE PATHWAY SELECTIVELY ENHANCES THE CHEMOTHERAPEUTIC POTENTIAL OF TEMOZOLOMIDE AND CLOMIPRAMINE IN STEM-CELL ENRICHED GLIOBLASTOMA
    Donovan, Laura K.
    Birks, Suzanne M.
    Bosak, Viktoria
    Pilkington, Geoffrey J.
    NEURO-ONCOLOGY, 2012, 14 : 142 - 142
  • [30] Ruxolitinib enhances cytotoxic and apoptotic effects of temozolomide on glioblastoma cells by regulating WNT signaling pathway-related genes
    Bagca, Bakiye Goker
    Ozates, Neslihan Pinar
    Avci, Cigir Biray
    MEDICAL ONCOLOGY, 2022, 40 (01)